TrialBMJ open2020

Laparoscopic bowel resection combined with infliximab treatment (LaRIC) versus infliximab for terminal ileitis in Crohn's disease: a randomised, controlled, open-label trial.

Xiuxiu Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.